Common Fatty Markers in Diseases with Dysregulated Lipogenesis

Publication date: Available online 26 March 2019Source: Trends in Endocrinology & MetabolismAuthor(s): David Balgoma, Curt Pettersson, Mikael HedelandRecent studies have reported the upregulation of a subgroup of triacylglycerides as markers of different diseases with dysregulated lipogenesis, which means that these markers are not selective. This observation has a deep impact on their use as diagnostic tools in clinical practice (e.g., markers of risk of type 2 diabetes).
Source: Trends in Endocrinology and Metabolism - Category: Endocrinology Source Type: research